Literature DB >> 23204410

Enterohemorrhagic Escherichia coli O157:H7 survival in an in vitro model of the human large intestine and interactions with probiotic yeasts and resident microbiota.

Jonathan Thévenot1, Lucie Etienne-Mesmin, Sylvain Denis, Sandrine Chalancon, Monique Alric, Valérie Livrelli, Stéphanie Blanquet-Diot.   

Abstract

This is the first report on the fate of enterohemorrhagic Escherichia coli O157:H7 in simulated human colonic conditions. The pathogen was progressively eliminated from the bioreactor and did not modify the major populations of resident microbiota. The coadministration of the Saccharomyces cerevisiae CNCM I-3856 probiotic strain led to a significant increase in acetate production but did not reduce pathogen viability.

Entities:  

Mesh：

Year:  2012        PMID： 23204410      PMCID： PMC3568547          DOI： 10.1128/AEM.03303-12

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN： 0099-2240            Impact factor:   4.792


  52 in total

1.  Comparative study of bacterial groups within the human cecal and fecal microbiota.

Authors:  P Marteau; P Pochart; J Doré; C Béra-Maillet; A Bernalier; G Corthier
Journal:  Appl Environ Microbiol       Date:  2001-10       Impact factor: 4.792

2.  The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.

Authors:  C S Wong; S Jelacic; R L Habeeb; S L Watkins; P I Tarr
Journal:  N Engl J Med       Date:  2000-06-29       Impact factor: 91.245

3.  Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR.

Authors:  Xander W Huijsdens; Ronald K Linskens; Mariëtte Mak; Stephan G M Meuwissen; Christina M J E Vandenbroucke-Grauls; Paul H M Savelkoul
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

4.  The clinical significance of colonoscopy in hemorrhagic colitis due to enterohemorrhagic Escherichia coli O157:H7 infection.

Authors:  T Shigeno; T Akamatsu; K Fujimori; Y Nakatsuji; A Nagata
Journal:  Endoscopy       Date:  2002-04       Impact factor: 10.093

5.  Nonpathogenic Escherichia coli can contribute to the production of Shiga toxin.

Authors:  Shantini D Gamage; Jane E Strasser; Claudia L Chalk; Alison A Weiss
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

6.  Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells.

Authors:  Stephanie Dahan; Guillaume Dalmasso; Veronique Imbert; Jean-Francois Peyron; Patrick Rampal; Dorota Czerucka
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

7.  Ethanol-mediated variations in cellular fatty acid composition and protein profiles of two genotypically different strains of Escherichia coli O157:H7.

Authors:  R Y-Y Chiou; R D Phillips; P Zhao; M P Doyle; L R Beuchat
Journal:  Appl Environ Microbiol       Date:  2004-04       Impact factor: 4.792

8.  Improved extraction of PCR-quality community DNA from digesta and fecal samples.

Authors:  Zhongtang Yu; Mark Morrison
Journal:  Biotechniques       Date:  2004-05       Impact factor: 1.993

9.  Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7.

Authors:  Takashi Asahara; Kensuke Shimizu; Koji Nomoto; Takashi Hamabata; Ayako Ozawa; Yoshifumi Takeda
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

10.  Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study.

Authors:  Jan Menne; Martin Nitschke; Robert Stingele; Mariam Abu-Tair; Jan Beneke; Jörn Bramstedt; Jan P Bremer; Reinhard Brunkhorst; Veit Busch; Reinhard Dengler; Günther Deuschl; Klaus Fellermann; Helmut Fickenscher; Christoph Gerigk; Alexander Goettsche; Jobst Greeve; Carsten Hafer; Friedrich Hagenmüller; Hermann Haller; Stefan Herget-Rosenthal; Bernd Hertenstein; Christina Hofmann; Melanie Lang; Jan T Kielstein; Ulrich C Klostermeier; Johannes Knobloch; Markus Kuehbacher; Ulrich Kunzendorf; Hendrik Lehnert; Michael P Manns; Tobias F Menne; Tobias N Meyer; Claus Michael; Thomas Münte; Christine Neumann-Grutzeck; Jens Nuernberger; Hermann Pavenstaedt; Leyla Ramazan; Lutz Renders; Jonas Repenthin; Wolfgang Ries; Axel Rohr; Lars Christian Rump; Ola Samuelsson; Friedhelm Sayk; Bernhard M W Schmidt; Sabine Schnatter; Harald Schöcklmann; Stefan Schreiber; Cay U von Seydewitz; Jürgen Steinhoff; Sylvia Stracke; Sebastian Suerbaum; Andreas van de Loo; Martin Vischedyk; Karin Weissenborn; Peter Wellhöner; Monika Wiesner; Sebastian Zeissig; Jürgen Büning; Mario Schiffer; Tanja Kuehbacher
Journal:  BMJ       Date:  2012-07-19
View more
  9 in total

1.  Linking microbial community structure to function in representative simulated systems.

Authors:  Ian M Marcus; Hailey A Wilder; Shanin J Quazi; Sharon L Walker
Journal:  Appl Environ Microbiol       Date:  2013-02-08       Impact factor: 4.792

2.  In vitro adhesion properties of Shiga toxin-producing Escherichia coli isolated from cattle, food, and humans.

Authors:  Nathalie Pradel; Lucie Etienne-Mesmin; Jonathan Thévenot; Charlotte Cordonnier; Stéphanie Blanquet-Diot; Valérie Livrelli
Journal:  Front Microbiol       Date:  2015-02-27       Impact factor: 5.640

3.  Enterohemorrhagic Escherichia coli pathogenesis: role of Long polar fimbriae in Peyer's patches interactions.

Authors:  Charlotte Cordonnier; Lucie Etienne-Mesmin; Jonathan Thévenot; Amandine Rougeron; Sandra Rénier; Benoit Chassaing; Arlette Darfeuille-Michaud; Nicolas Barnich; Stéphanie Blanquet-Diot; Valérie Livrelli
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

Review 4.  Management of STEC Gastroenteritis: Is There a Role for Probiotics?

Authors:  Mario Giordano; Maria Elisabetta Baldassarre; Viviana Palmieri; Diletta D Torres; Vincenza Carbone; Luisa Santangelo; Federico Gentile; Raffaella Panza; Federica Di Mauro; Manuela Capozza; Antonio Di Mauro; Nicola Laforgia
Journal:  Int J Environ Res Public Health       Date:  2019-05-12       Impact factor: 3.390

Review 5.  Modulation of Enterohaemorrhagic Escherichia coli Survival and Virulence in the Human Gastrointestinal Tract.

Authors:  Grégory Jubelin; Mickaël Desvaux; Stephanie Schüller; Lucie Etienne-Mesmin; Maite Muniesa; Stéphanie Blanquet-Diot
Journal:  Microorganisms       Date:  2018-11-19

6.  Optimization of probiotic therapeutics using machine learning in an artificial human gastrointestinal tract.

Authors:  Susan Westfall; Francesca Carracci; Molly Estill; Danyue Zhao; Qing-Li Wu; Li Shen; James Simon; Giulio Maria Pasinetti
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 7.  Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection.

Authors:  Ludovica F Buttó; Monika Schaubeck; Dirk Haller
Journal:  Front Immunol       Date:  2015-11-19       Impact factor: 7.561

8.  Dynamic In Vitro Models of the Human Gastrointestinal Tract as Relevant Tools to Assess the Survival of Probiotic Strains and Their Interactions with Gut Microbiota.

Authors:  Charlotte Cordonnier; Jonathan Thévenot; Lucie Etienne-Mesmin; Sylvain Denis; Monique Alric; Valérie Livrelli; Stéphanie Blanquet-Diot
Journal:  Microorganisms       Date:  2015-10-23

Review 9.  AB5 Enterotoxin-Mediated Pathogenesis: Perspectives Gleaned from Shiga Toxins.

Authors:  Erika N Biernbaum; Indira T Kudva
Journal:  Toxins (Basel)       Date:  2022-01-16       Impact factor: 4.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.